Latest news:
FDA Announces Shift Away from Mandatory Animal Testing – BioReperia Offers a Validated, Human-Relevant Alternative
Read more
/

Charles River’s science blog features the zebrafish model

Charles River Laboratories recently shared an interesting article called “What’s Hot in 2020: Oncology”, in which they present how the zebrafish model contributes to great progresses within cancer discovery.

“The predictive and robustness of the zebrafish platform as a part of the drug development process will elucidate the value of this emerging technology. Specifically for oncology, zebrafish platforms have the potential to drive major breakthroughs as the zebrafish mimic the process of invasion and metastasis in a realistic and robust manner.” — Julia Schüler, DVM, PhD, Research Director, Discovery Oncology Charles River

This website uses cookies

We use essential cookies to make our website work. With your consent, we also use non-essential cookies to improve the user experience and analyze website traffic. You can change your cookie settings at any time by clicking on Cookie settings..

Which cookies do you want to accept?

This website uses cookies

We use different types of cookies to optimize your experience on our website. Click on the categories below to learn more about their purposes. You can choose which types of cookies to allow and can change your settings at any time. Remember that disabling cookies may affect your experience on the website.

Which cookies do you want to accept?

These cookies are essential for the proper functioning of the website and cannot be disabled.

These cookies collect information about how you use our website. All of the data is anonymized and cannot be used to identify you.

Read more about Google's privacy policy and terms of use